This pharmaceutical company, operating for over a decade in the European market, focuses on providing cost-effective, high-quality drugs. They cater to both the medical community and patients, offering a range of products and trusted medical information. Their commitment to quality is evident in their adherence to EU GMP standards. While the company's website doesn't delve into specific therapy areas, their mission suggests a focus on delivering essential medications across various medical needs. Their production lines include both prescription and over-the-counter medications, available in various dosage forms such as solids, liquids, and injectables. Although specific product patents aren't explicitly mentioned, their dedication to providing novel products hints at ongoing research and development efforts.
Manufacturer usually replies in 8 days
Cefepime is an antibiotic used to treat a wide range of bacterial infections, including intraabdominal, kidney, skin, urinary tract infections as well as pneumonia. Suppliers of cefepime market it in the form of powders for injectable solutions.
The developer and earliest manufacturer of cefepime is Bristol-Myers Squibb who first introduced it into the market in 1994 under the trade name Maxipime. Currently, major manufacturers of cefepime medications include companies such as Berr Chem, Hangzhou Viwa, Nectar Lifesciences, ACS Dobfar, and Qilu Pharmaceutical.
Cefepime suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified cefepime manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.
The retail prices per 10g of cefepime powder falls into an approximate range of 120 EUR to 160 EUR.